215 related articles for article (PubMed ID: 29269306)
1. Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease.
Wylie SA; van Wouwe NC; Godfrey SG; Bissett PG; Logan GD; Kanoff KE; Claassen DO; Neimat JS; van den Wildenberg WPM
Neuropsychologia; 2018 Jan; 109():262-269. PubMed ID: 29269306
[TBL] [Abstract][Full Text] [Related]
2. Deep-brain stimulation of the subthalamic nucleus improves overriding motor actions in Parkinson's disease.
van den Wildenberg WPM; van Wouwe NC; Ridderinkhof KR; Neimat JS; Elias WJ; Bashore TR; Wylie SA
Behav Brain Res; 2021 Mar; 402():113124. PubMed ID: 33422595
[TBL] [Abstract][Full Text] [Related]
3. Overriding actions in Parkinson's disease: Impaired stopping and changing of motor responses.
van den Wildenberg WPM; Ridderinkhof KR; van Wouwe NC; Neimat JS; Bashore TR; Wylie SA
Behav Neurosci; 2017 Oct; 131(5):372-84. PubMed ID: 28805433
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
[TBL] [Abstract][Full Text] [Related]
5. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
[TBL] [Abstract][Full Text] [Related]
6. A model-based quantification of action control deficits in Parkinson's disease.
Servant M; van Wouwe N; Wylie SA; Logan GD
Neuropsychologia; 2018 Mar; 111():26-35. PubMed ID: 29360609
[TBL] [Abstract][Full Text] [Related]
7. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications.
Kim J; Zhang K; Cai W; YorkWilliams S; Ua Cruadhlaoich MAI; Llanes S; Menon V; Poston KL
Neuropsychologia; 2018 Oct; 119():24-33. PubMed ID: 30040957
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic modulation of motor network dynamics in Parkinson's disease.
Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321
[TBL] [Abstract][Full Text] [Related]
10. Pre- and unplanned walking turns in Parkinson's disease - Effects of dopaminergic medication.
Conradsson D; Paquette C; Lökk J; Franzén E
Neuroscience; 2017 Jan; 341():18-26. PubMed ID: 27867059
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of novelty repetition in Parkinson's disease: A study of P3 event-related brain potentials.
Bertram M; Warren CV; Lange F; Seer C; Steinke A; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B
Clin Neurophysiol; 2020 Dec; 131(12):2841-2850. PubMed ID: 33137574
[TBL] [Abstract][Full Text] [Related]
12. The influence of dopaminergic medication on balance automaticity in Parkinson's disease.
Workman CD; Thrasher TA
Gait Posture; 2019 May; 70():98-103. PubMed ID: 30836253
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease Subtypes Show Distinct Tradeoffs Between Response Initiation and Inhibition Latencies.
Tolleson C; Turchan M; van Wouwe N; Isaacs D; Phibbs F; Wylie S
J Int Neuropsychol Soc; 2017 Sep; 23(8):665-674. PubMed ID: 28850018
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
16. Sequence learning in Parkinson's disease: Focusing on action dynamics and the role of dopaminergic medication.
Ruitenberg MFL; Duthoo W; Santens P; Seidler RD; Notebaert W; Abrahamse EL
Neuropsychologia; 2016 Dec; 93(Pt A):30-39. PubMed ID: 27702597
[TBL] [Abstract][Full Text] [Related]
17. The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.
Jahanshahi M; Brown RG; Marsden CD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1168-76. PubMed ID: 1362212
[TBL] [Abstract][Full Text] [Related]
18. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
[TBL] [Abstract][Full Text] [Related]
19. Applied strategy in the Iowa Gambling Task: Comparison of individuals with Parkinson's disease to healthy controls.
Kjær SW; Callesen MB; Larsen L; Borghammer P; Østergaard K; Damholdt MF
J Clin Exp Neuropsychol; 2020 Jul; 42(5):425-435. PubMed ID: 32283989
[TBL] [Abstract][Full Text] [Related]
20. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
